Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TLSA Tiziana Life Sciences PLC

Market Closed 09-25 16:00:00 EDT

1.01

-0.03

-2.88%

盘后1.01

+0.000.00%

19:30 EDT

High1.08	Low1.00	Vol382.73K
Open1.03	D1 Closing1.04	Amplitude7.69%
Mkt Cap128.27M	Tradable Cap65.53M	Total Shares127.00M
T/O392.76K	T/O Rate0.59%	Tradable Shares64.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TLSA","market":"US","secType":"STK","nameCN":"Tiziana Life Sciences PLC","latestPrice":1.01,"timestamp":1790366400000,"preClose":1.04,"halted":0,"volume":382729,"hourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.01,"latestTime":"19:30 EDT","volume":44,"amount":44.1,"timestamp":1790379004333,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.028846153846153872,"floatShares":64882543,"shares":127000000,"eps":-0.155821,"marketStatus":"Market Closed","change":-0.03,"latestTime":"09-25 16:00:00 EDT","open":1.03,"high":1.08,"low":1,"amount":392764.9581109,"amplitude":0.076923,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.155821,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790582400000},"marketStatusCode":7,"adr":0,"adrRate":2,"listingDate":1542690000000,"exchange":"NASDAQ","adjPreClose":1.04,"preHourTrading":{"tag":"盘前","latestPrice":1.04,"preClose":1.04,"latestTime":"08:43 EDT","volume":2021,"amount":2083.3001544,"timestamp":1790340216719,"change":0,"changeRate":0,"amplitude":0.022788},"postHourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.01,"latestTime":"19:30 EDT","volume":44,"amount":44.1,"timestamp":1790379004333,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4954523330253735,"impliedVol":1.1411,"impliedVolPercentile":0.8725},"requestUrl":"/m/hq/s/TLSA","defaultTab":"news","newsList":[{"id":"2669143724","title":"Tiziana Life Sciences Price Target Maintained with a $7.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143724?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:15","pubTimestamp":1790072100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSA/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150572","title":"Tiziana Life Sciences Completes Phase 2a Inform-MS Last Patient Visit for Intranasal Foralumab in Na-SPMS","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150572","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150572?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988434,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences completes Phase 2a INFORM-MS last patient visit for intranasal foralumab in na-SPMSTiziana reported the last patient completed the final visit in its Phase 2a INFORM-MS trial of ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL6nv9KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150511","title":"Tiziana Announces Last Patient Completes Last Visit in Phase 2a Inform-MS Trial of Intranasal Foralumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150511?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA5D53JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668344961","title":"Tiziana Life Sciences signs MOU with KAIMRC in Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2668344961","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668344961?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:15","pubTimestamp":1789643725,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) announced the signing of a memorandum of understanding, or MOU, with the King Abdullah International Medical Research ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-signs-mou-with-kaimrc-in-saudi-arabia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-signs-mou-with-kaimrc-in-saudi-arabia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969492","title":"Tiziana Life Sciences Signs MOU at Riyadh Global Medical Biotechnology Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969492","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969492?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:05","pubTimestamp":1789643119,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences signs MOU at Riyadh Global Medical Biotechnology SummitTiziana signed an MOU at the Riyadh Global Medical Biotechnology Summit in Riyadh on September 16, 2026.Agreement targets a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL35lZZf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969689","title":"Tiziana Life Sciences Announces Signing of Mou with King Abdullah International Medical Research Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969689?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:00","pubTimestamp":1789642845,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590MA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668696960","title":"Tiziana Life Sciences - Mou Covers Clinical Trial of Foralumab and Anti-Cd20 in Rrms Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2668696960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668696960?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:00","pubTimestamp":1789642845,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590MA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664299875","title":"Tiziana Life Sciences Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2664299875","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664299875?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:18","pubTimestamp":1788430680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSA/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664873409","title":"Tiziana Life Sciences Ltd : Btig Initiates Coverage with Buy Rating; Price Target $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2664873409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664873409?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:51","pubTimestamp":1788429094,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0IG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323273","title":"Tiziana Life Sciences Launches Phase 2a Banyan Trial of Intranasal Foralumab in ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323273","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323273?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569233,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences launches Phase 2a BANYAN trial of intranasal foralumab in ALSTiziana Life Sciences announced a Phase 2a BANYAN trial of intranasal foralumab in ALS within the Healey ALS MyMatch ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLsJD9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4588","LU2210149790.SGD","IE00BN0W2T93.GBP","TLSA","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4585","LU2210150020.SGD","IE00BQXX3F31.USD","BCDF","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00B64PRP62.GBP","BK4139","NDAQ","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","BK4112","IE00BQXX3D17.EUR","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273805","title":"Tiziana Life Sciences Announces Poster Presentation on Phase 2a Banyan Clinical Trial of Intranasal Foralumab at ALS Nexus 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273805","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273805?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA8XKWHH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638932","title":"Tiziana Life Sciences CEO Elrifi Buys USD 321,423 in Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638932","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638932?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:05","pubTimestamp":1786014311,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences CEO Elrifi buys USD 321,423 in sharesTiziana Life Sciences CEO Ivor Elrifi bought 321,423 common shares on Nasdaq at $1 per share.Holding increased to 4,793,684 common shares.Dis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL8MRBwz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tiziana Life Sciences CEO Elrifi Buys USD 321,423 in Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638625","title":"Press Release: Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638625","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638625?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014000,"startTime":"0","endTime":"0","summary":"BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (\"Tiziana\" or the \"Company\"), a biotechnology company developing breakthrough immunomodulation therapies with its l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1043141123.HKD","LU1430594728.SGD","LU0994945656.USD","LU0640476718.USD","ESPO","LU2506952170.USD","LU1043141396.HKD","LU0823417737.USD","LU1280957306.USD","LU2506952097.USD","LU1585245621.USD","LU0823417653.USD","LU0006061336.USD","NERD","BK4085","HERO","BK4139","BNGE","LU1121112475.USD","LU2247934214.USD","BK4585","BK4577","EA","LU0426412945.USD","BK4532","LU0950375773.USD","LU2506951875.HKD","TLSA","BK4588","LU0426417589.USD","BK4533","LU2506951958.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657573647","title":"Tiziana CEO Ivor Elrifi Acquires 667,000 Common Shares for $667,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2657573647","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657573647?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:32","pubTimestamp":1785961946,"startTime":"0","endTime":"0","summary":"Tiziana CEO Ivor Elrifi acquires 667,000 common shares for $667,000Tiziana Life Sciences CEO Ivor Elrifi reported an indirect purchase of 667,000 common shares at USD 1 per share.Indirect holdings hel","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL81yhT5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tiziana CEO Ivor Elrifi Acquires 667,000 Common Shares for $667,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656514530","title":"Tiziana Life Sciences CEO Ivor Elrifi Lifts Stake to 4,472,261 Shares After Buying 667,000 at $1 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2656514530","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656514530?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:00","pubTimestamp":1785841217,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences CEO Ivor Elrifi lifts stake to 4,472,261 shares after buying 667,000 at $1 apieceCEO Ivor Elrifi bought 667,000 Tiziana Life Sciences common shares on Nasdaq at $1 per share.The ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL5td0S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","BK4588","IE00BN0W2T93.GBP","NDAQ","BK4139","LU2210149790.SGD","IE00BGHQF748.EUR","BCDF","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","TLSA","SG9999014021.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656908530","title":"Press Release: Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2656908530","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656908530?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:00","pubTimestamp":1785841200,"startTime":"0","endTime":"0","summary":"BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (\"Tiziana\" or the \"Company\"), a biotechnology company developing breakthrough immunomodulation therapies with its l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1043141396.HKD","LU1121112475.USD","BK4588","ESPO","BK4532","LU0823417737.USD","LU1430594728.SGD","NERD","LU2247934214.USD","LU1280957306.USD","LU0640476718.USD","BK4139","BK4085","LU0823417653.USD","LU0950375773.USD","LU2506952097.USD","BK4533","LU2506951875.HKD","LU1585245621.USD","LU0426412945.USD","BNGE","LU2506951958.HKD","LU0994945656.USD","LU0006061336.USD","LU1043141123.HKD","LU0426417589.USD","TLSA","BK4577","BK4585","LU2506952170.USD","HERO","EA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655368159","title":"Tiziana Reports up to 34% Drop in Brain Inflammation in Third MSA Patient on Intranasal Foralumab in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2655368159","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655368159?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:04","pubTimestamp":1785495890,"startTime":"0","endTime":"0","summary":"Tiziana reports up to 34% drop in brain inflammation in third MSA patient on intranasal foralumab in Phase 2 trialTiziana Life Sciences reported Phase 2 PET imaging results from a third multiple syste","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDLNB35p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BN0W2W23.USD","NDAQ","SG9999014005.SGD","LU2210150020.SGD","TLSA","IE00BN0W2V16.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BCDF","IE00BN0W2T93.GBP","BK4588","BK4112","SG9999014013.SGD","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655686633","title":"Tiziana Life Sciences - Third MSA Patient Shows up to 34% Reduction in SUV and 26% in Suvr in Brain Regions","url":"https://stock-news.laohu8.com/highlight/detail?id=2655686633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655686633?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:01","pubTimestamp":1785495688,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X20I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655368661","title":"Tiziana Life Sciences - to Continue Evaluating Intranasal Foralumab in Additional MSA Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2655368661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655368661?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:01","pubTimestamp":1785495688,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X20I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653927775","title":"Tiziana Life Sciences CEO Ivor Elrifi Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653927775","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653927775?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:21","pubTimestamp":1784838070,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences CEO Ivor Elrifi files initial beneficial ownership statementTiziana Life Sciences CEO Ivor Elrifi reported 3,805,261 common shares, with 3,150,000 restricted stock units exercisa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL1DqJkY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tizianalifesciences.com","stockEarnings":[{"period":"1week","weight":0.1153},{"period":"1month","weight":-0.0734},{"period":"3month","weight":-0.1441},{"period":"6month","weight":-0.1855},{"period":"1year","weight":-0.5121},{"period":"ytd","weight":-0.3221}],"compareEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":0.0069},{"period":"3month","weight":0.0581},{"period":"6month","weight":0.2165},{"period":"1year","weight":0.1722},{"period":"ytd","weight":0.1311}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-  receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.062066},{"month":2,"riseRate":0.125,"avgChangeRate":0.000048},{"month":3,"riseRate":0.375,"avgChangeRate":0.130911},{"month":4,"riseRate":0.625,"avgChangeRate":0.144279},{"month":5,"riseRate":0.5,"avgChangeRate":0.187138},{"month":6,"riseRate":0.375,"avgChangeRate":-0.011823},{"month":7,"riseRate":0.375,"avgChangeRate":0.26158},{"month":8,"riseRate":0.25,"avgChangeRate":-0.130353},{"month":9,"riseRate":0.375,"avgChangeRate":-0.011295},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.076885},{"month":11,"riseRate":0,"avgChangeRate":-0.127748},{"month":12,"riseRate":0,"avgChangeRate":-0.132657}],"exchange":"NASDAQ","name":"Tiziana Life Sciences PLC","nameEN":"Tiziana Life Sciences PLC","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tiziana Life Sciences PLC(TLSA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tiziana Life Sciences PLC,TLSA,Tiziana Life Sciences PLC股票,Tiziana Life Sciences PLC股票老虎,Tiziana Life Sciences PLC股票老虎国际,Tiziana Life Sciences PLC行情,Tiziana Life Sciences PLC股票行情,Tiziana Life Sciences PLC股价,Tiziana Life Sciences PLC股市,Tiziana Life Sciences PLC股票价格,Tiziana Life Sciences PLC股票交易,Tiziana Life Sciences PLC股票购买,Tiziana Life Sciences PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tiziana Life Sciences PLC(TLSA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}